Dream It

SEPTEMBER 25, 2020

In this Dreamit Dose, Healthtech MD Adam Dakin provides 5 simple rules to avoid giving investors the wrong impression when pitching remotely. Watch Adam’s full Dreamit Dose below. This matters because it brings new issues to light that simply were not as relevant to investors before. Mistake #1 - Showing Up Late. Read Part 1.

pitching 285

pitching advice health founder 285

OurCrowd

MARCH 30, 2021

The post [Insightec in globes Newswire] Ivy Brain Tumor Center, SonALAsense and Insightec Announce the First Patient Dosed in First-in-Human Clinical Trial of Noninvasive Sonodynamic Therapy for the Treatment of Brain Cancer appeared first on OurCrowd Blog. Read more here.

collaboration 36

collaboration development 36

Dream It

FEBRUARY 1, 2022

In this Dose, Mike Ravenscroft , Startup Success Manager of Dreamit Healthtech, reveals his top five common mistakes founders make when answering customer and investor questions. During Q&A, both sides start engaging in a sort of conversational dance - with one side leading (VC/customer) and the other side following (founder).

VC 513

VC pitching health founder 513

Entrepreneur - Entrepreneurs Category

FEBRUARY 16, 2023

Renee Blount built a business around her love of the outdoors, storytelling and a healthy dose of whimsey.

creativity 97

creativity entrepreneurs founder 97

Entrepreneur's Handbook

MARCH 9, 2022

Let me save you $15k+ and the promise of 6-figures more with a healthy dose of financially-steeped reality. Continue reading on Entrepreneur's Handbook ».

entrepreneurs 100

entrepreneurs entrepreneurship startup 100

Dream It

MAY 19, 2021

In this Dreamit Dose, Managing Director Adam Dakin presents his view on the right way to answer it after hearing hundreds, if not thousands, of founder pitches. The ‘How much are you raising?’ question is a common and important component of investor Q&A. Seasoned founders have a particular way of answering this question.

pitching 393

pitching board health VC 393

UBI Global

MAY 6, 2019

A Question of Innovation… Corporations may recognize that they could use a good dose of innovation, and some seek startups as a shortcut to creative thinking. They may become enamored by a startup’s product, service, or even social focus.

innovation 100

innovation startup creativity investing 100

A VC: Musings of a VC in NYC

JUNE 13, 2023

In closing, I’d like to address this tweet from Liad , a longtime AVC reader: I understand that a daily dose of anything is a great thing. But I have never planned out my writing. I like to let it flow out of me in the moment. I love my daily flat white (cortado in the summer). But these are not dark times we are in.

energy 229

energy health VC innovation 229

TechCrunch

APRIL 6, 2023

The first day’s demos included a healthy dose of artificial intelligence and open source, which is different from years past that were dominated by new fintech companies. Over 20,000 applications flew into Y Combinator, which ended up plucking out 282 startups for its latest batch.

startup 100

startup advice investing investment 100

Dream It

JULY 29, 2020

By Elliot Levy , Healthtech Associate at Dreamit Ventures Check out the Dreamit Dose, actionable insight for founders in 5-minute videos. For more information, visit trekit.health. Learn more about Dreamit Healthtech , a growth-focused program for digital health and medtech startups with revenue, pilots, or early product-market fit.

health 221

health enablement financing finance 221

TechCrunch

JANUARY 7, 2023

It is always nice to start a new year with a dose of optimism — as long as it is warranted. elcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here.

venture capital 84

venture capital ventures capital investing 84

Andreessen Horowitz

NOVEMBER 16, 2023

New modalities are often challenging and expensive to develop and manufacture—gene therapy can be $2 million+ per dose! Convenience of dosing helped Evrysdi quickly gain market traction. Many patients simply cannot afford or access them, so less expensive approaches like small molecules are more likely to reach those patients.

innovation 120

innovation development enablement investing 120

A VC: Musings of a VC in NYC

JANUARY 1, 2021

All of this will be aided by at least two additional approved vaccines in the US in January and new and improved protocols, like emphasizing the first dose over the second one. By the end of the second quarter in the US, anyone who wants to be vaccinated will have been able to do so.

real estate 279

real estate financing finance accelerator 279

Dream It

SEPTEMBER 16, 2020

Watch Caya’s full Dreamit Dose below. Choose your partners wisely - whether it’s $100k in revenue or another relative inflection point, make sure your cofounders can get there without hiring any external talent. Check out Slidebean to design your next pitch deck.

startup 195

startup frameworks pitching health 195

Dream It

APRIL 26, 2019

Connected medical devices offer many exciting benefits such as remote patient monitoring, automated dose adjustments, “smart” implants, and simpler imaging file transfers. Just imagine if a connected device gets compromised and delivers a toxic dose of insulin or adds malignant-looking growths to a healthy CT scan—that would be a disaster.

hospitality 250

hospitality startup health networking 250

OurCrowd

JUNE 17, 2022

Low-doses of medical cannabis delivered through an inhaler significantly reduced pain in patients with neuropathy, back pain and other chronic pain conditions, according to a new study. The post [Syqe in Pain News Network] Low-dose cannabis inhaler effective in treating chronic pain appeared first on OurCrowd Blog. Read more here.

networking 36

networking 36

Dream It

DECEMBER 10, 2020

In this guest Dreamit Dose, Jason Calacanis (@jason), a technology entrepreneur, angel investor, and the host of the popular podcasts This Week in Startups and Angel, answers the top 5 questions he gets about angel investing.

angel investing 221

angel investing investing investment networking 221

Dream It

JULY 12, 2021

In this Dreamit Dose, Steve Barsh, Managing Partner at Dreamit, gives you his breakdown and tells you what issues to avoid on these early-stage financing instruments. Raising early-stage funding? You’ll need to know the ins and outs of convertible notes and SAFEs.

founder 397

founder financing finance angel investing 397

Entrepreneur's Handbook

JUNE 16, 2023

Join us for an exciting new dose of entrepreneurial goodness Some of you may have received our latest newsletter on Tuesday, and noticed it looks a little different. Well, we’re excited to announce that the weekly EH newsletter has moved to Beehiiv! If you didn’t receive, you can sign up right here. Why the change? There are two main reasons.

communities 52

communities entrepreneurs founder entrepreneurship 52

Entrepreneur's Handbook

JUNE 6, 2023

Join us for an exciting new dose of entrepreneurial goodness Some of you may have received our newsletter today and noticed it looks a little different… well, we’re excited to announce that the weekly EH newsletter has moved to Beehiiv. If you didn’t, you can sign up right here. Why the change? There are two main reasons.

communities 52

communities entrepreneurs founder entrepreneurship 52

TechCrunch

APRIL 18, 2023

Despite its accuracy, high-dose radiation exposure, a relatively high price and long wait times for final results are the drawbacks of a cardiac CT scan. Mediwhale’s tech offers results in under a minute, according to Choi. Medical professionals typically use computerized cardiac tomography (CT) scans to predict CVD risk.

startup 81

startup health hospitality financing 81

OurCrowd

APRIL 11, 2022

Eran Fine, TV show creator and director, a serial entrepreneur, and currently CEO/Founder of Nanolock Security, shows that the tech world definitely requires a dose of humour. Creativity is known for spurring innovation – so how does that translate when you move from comedy television to tech? Read more here.

technology 36

technology creativity innovation entrepreneurs 36

Dream It

NOVEMBER 18, 2020

If you don’t know what that means, go watch the Dreamit Dose listed on the right. Watch the Dose on the right to help optimize how you present your competition slide to investors. Watch the Dose listed here on how to present a killer GTM strategy when you’re in front of investors. How Are you Clever? What’s Your Go To Market?

VC 364

VC pitching founder strategy 364

Dream It

DECEMBER 22, 2020

In this dose, Mel covers the lessons he’s learned from leading product teams that can make or break your startup. Recently, Mel served as the SVP of Product Development at Securonix and Director of Product Management at RSA NetWitness. Mel knows firsthand how crucial strategy is to develop products that customers love.

strategy 195

strategy innovation culture collaboration 195

Dream It

SEPTEMBER 28, 2020

In this Dreamit Dose, Mel gives you 5 reasons a CISO may NOT buy your product. Mel Shakir , Securetech Managing Director, talks to CISOs every day in his role at Dreamit. He coaches companies to get them ready to sell to a CISO. However, he also coaches them on what to avoid. You can watch the whole episode below: 1.

disruption 195

disruption SaaS frameworks pitching 195

TechCrunch

MAY 4, 2022

Based on the seminal work of Charles Nichols, certain psychedelic compounds appear to be potently anti-inflammatory at very low doses. Besides having broad applications across a range of inflammatory disorders, it also opens up a new mechanism underlying inflammatory pathways.

health 94

health startup incumbents ventures 94

OurCrowd

JANUARY 25, 2024

The post [Biolojic in Business Wire] First Patient Dosed in Phase 2 Portion of Aulos Bioscience’s Phase 1/2 Clinical Trial for AU-007, a Computationally Designed IL-2 Antibody for Solid Tumor Cancers appeared first on OurCrowd Blog.

36

36

Entrepreneurs' Organization

MAY 20, 2022

We provide non-dosed confection products to CBD/THC edible manufacturers—such as our meltable gummy base. Increased costs and escalating lead times have impacted our profits negatively, but we have worked with customers to hold off on price increases as long as possible.”. Think outside the box. “We

transportation 259

transportation mix-use creativity strategy 259

OurCrowd

FEBRUARY 1, 2023

.–(BUSINESS WIRE)–Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced that the first patient has been dosed in the United States in its Phase 1/2 clinical trial evaluating AU-007 for the treatment of solid tumors.

development 36

development 36

OurCrowd

JULY 2, 2020

Israeli researchers have conducted clinical trials seeking to demonstrate that pain can be effectively relieved using targeted micro-doses of THC. The post [Syqe in Yahoo Finance] Very Low Doses Of THC Can Help Treat Pain appeared first on OurCrowd. Read more here.

financing 36

financing finance 36

Tomasz Tunguz

OCTOBER 10, 2020

But, take any sequential quarterly analysis on seed trends with a massive dose of skeptical patience. Take heart that these variances also occurred during a period of tremendous background macroeconomic volatility, and still the Series A and later figures are still within 10%. The data is still coming in.

venture capital 136

venture capital capital ventures investing 136

Ben Franklin Technology Partners

JUNE 15, 2022

The team of Seth Pheng and Soph Horn at Control LTD, took first place with their concept for a patented, healthy dosing system for patients using cannabis. On Tuesday, June 14, 2022, beginning at 2:00 PM, the teams pitched their business concepts to a panel of independent judges for a cash prize of $10,000!

pitching 40

pitching mix-use creativity energy 40

Innovation 2 Enterprise

DECEMBER 27, 2020

I have been thinking about that lesson over the last few day, ever since the first doses of COVID-19 vaccine began shipping and healthcare workers and others began receiving shots. When I was a boy, I learned from my grandparents that when something bad t happened, that something good would come out of it. This has been a really bad year.

collaboration 40

collaboration innovation health technology 40

OurCrowd

APRIL 27, 2020

Daily Dose. Here’s the latest from Daily Dose: one-minute insight videos based on the news, technologies, and stories I’m seeing and hearing each day. For the whole playlist, click here and catch up. .

hospitality 53

hospitality innovation investing investment 53

TechCrunch

DECEMBER 15, 2022

“Our approach is to be open access and to create additional products for folks who want an extra dose of convenience, savings and support,” Hinson said, adding that Juno is more focused on offering family care at scale. Juno wants to be for people who don’t fit into either category, which it thinks is 99% of the population.

health 76

health enablement venture capital ventures 76

OurCrowd

JULY 1, 2020

controlled study was conducted between March 2016 and July 2017 with 25 patients of a mean age of 48 at the Pain Research Unit of the Rambam Health Care Campus in Haifa in partnership with Israeli medical device firm Syqe Medical, the developer of the world’s first selective-dose, pharmaceutical-grade medicinal plants inhalers.

health 36

health development 36

OurCrowd

NOVEMBER 3, 2023

The post [Biolojic in Business Wire] New phase 1 dose escalation data show well-tolerated safety profile and anti-tumor activity for Aulos Bioscience’s AU-007 at Society for Immunotherapy of Cancer (SITC) Annual Meeting appeared first on OurCrowd Blog.

28

28